Camurus Annual Report for 2018
Lund, Sweden — 15 April 2019 — Camurus (CAMX) today announces that the Annual Report for 2018 now is available at the company’s website: www.camurus.com. About CamurusCamurus is a Swedish science-led biopharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the